Language

Medicine shortages: Czechia · Page 7

Official notices covering supply interruptions, limited availability and resumed supply. Each notice identifies the product, active ingredient, status and reported period.

Data checked:

970 notices · Page 7 / 20

← Europe overview

National authority sources: Czechia

Recorded notices include resolved cases. The data check date differs from the modification date of an individual authority notice.

Medicine shortages: Czechia · Page 7

Czechia

ORCAL NEO 10MG TBL NOB 30 I

Marketing resumed · Not specified
Active ingredient: AMLODIPIN

Notice details →
Czechia

ORTANOL 20MG CPS ETD 56

Marketing resumed · Not specified
Active ingredient: OMEPRAZOL

Notice details →
Czechia

OXALICUM ACIDUM 3CH-200CH GRA 1X4G

Marketing ended · Zánik/zrušení registrace
Active ingredient: HOMEOPATIKA (ČESKÁ ATC SKUPINA)

Notice details →
Czechia

OXALICUM ACIDUM 3K-10MK GRA 1X4G

Marketing ended · Zánik/zrušení registrace
Active ingredient: HOMEOPATIKA (ČESKÁ ATC SKUPINA)

Notice details →
Czechia

PIX LIQUIDA 3CH-200CH GRA 1X4G

Marketing ended · Zánik/zrušení registrace
Active ingredient: HOMEOPATIKA (ČESKÁ ATC SKUPINA)

Notice details →
Czechia

PIX LIQUIDA 3K-10MK GRA 1X4G

Marketing ended · Zánik/zrušení registrace
Active ingredient: HOMEOPATIKA (ČESKÁ ATC SKUPINA)

Notice details →
Czechia

PREGABALIN TEVA 75MG CPS DUR 60

Unterbrechung des Inverkehrbringens · Commercial/marketing reasons
Active ingredient: PREGABALIN

Notice details →
Czechia

PREGABALIN TEVA 75MG CPS DUR 90

Unterbrechung des Inverkehrbringens · Commercial/marketing reasons
Active ingredient: PREGABALIN

Notice details →
Czechia

REPARIL DRAGÉES 20MG TBL ENT 100

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: JINÉ KAPILÁRY STABILIZUJÍCÍ LÁTKY

Notice details →
Czechia

ROSUVASTATIN TEVA PHARMA 10MG TBL FLM 90 II

Unterbrechung des Inverkehrbringens · Commercial/marketing reasons
Active ingredient: ROSUVASTATIN

Notice details →
Czechia

ROSUVASTATIN TEVA PHARMA 20MG TBL FLM 90 II

Unterbrechung des Inverkehrbringens · Commercial/marketing reasons
Active ingredient: ROSUVASTATIN

Notice details →
Czechia

ROSUVASTATIN TEVA PHARMA 40MG TBL FLM 30 II

Marketing resumed · Not specified
Active ingredient: ROSUVASTATIN

Notice details →
Czechia

SODIUM CHLORIDE FRESENIUS KABI 0,9% 9MG/ML INF SOL 10X1000ML I

Unterbrechung des Inverkehrbringens · Capacity/distribution reasons
Active ingredient: ELEKTROLYTY

Notice details →
Czechia

ULTRACOD 500MG/30MG TBL NOB 10

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: KODEIN A PARACETAMOL

Notice details →
Czechia

VIOLA TRICOLOR 2CH-200CH GRA 1X4G

Marketing ended · Zánik/zrušení registrace
Active ingredient: HOMEOPATIKA (ČESKÁ ATC SKUPINA)

Notice details →
Czechia

VIOLA TRICOLOR 3K-10MK GRA 1X4G

Marketing ended · Zánik/zrušení registrace
Active ingredient: HOMEOPATIKA (ČESKÁ ATC SKUPINA)

Notice details →
Czechia

WATER FOR INJECTION FRESENIUS KABI 100% PAR LQF 20X250ML II

Unterbrechung des Inverkehrbringens · Capacity/distribution reasons
Active ingredient: ROZPOUŠTĚDLA A ŘEDIDLA, VČETNĚ IRIGAČNÍCH ROZTOKŮ

Notice details →
Czechia

ZENON NEO 40MG/10MG TBL FLM 90

Marketing resumed · Not specified
Active ingredient: ROSUVASTATIN A EZETIMIB

Notice details →
Czechia

ALZIL 10MG TBL FLM 98

Marketing ended · Commercial/marketing reasons
Active ingredient: DONEPEZIL

Notice details →
Czechia

BERIRAB 300IU INJ SOL ISP 1X2ML

Marketing resumed · Not specified
Active ingredient: IMUNOGLOBULIN PROTI VZTEKLINĚ

Notice details →
Czechia

BUCCOLAM 10MG ORM SOL 4X2ML

Marketing resumed · Not specified
Active ingredient: MIDAZOLAM

Notice details →
Czechia

CASARO 32MG TBL NOB 30 I

Marketing resumed · Not specified
Active ingredient: KANDESARTAN

Notice details →
Czechia

CONVERIDE 300MG/12,5MG TBL FLM 30 II

Marketing resumed · Not specified
Active ingredient: IRBESARTAN A DIURETIKA

Notice details →
Czechia

COTRIMOXAZOL AL FORTE 800MG/160MG TBL NOB 20

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: SULFAMETHOXAZOL A TRIMETHOPRIM

Notice details →
Czechia

DERMOVATE 0,5MG/G CRM 1X25G

Marketing ended · Change to another SÚKL code
Active ingredient: KLOBETASOL

Notice details →
Czechia

DIAZEPAM DESITIN 10MG RCT SOL 5X2,5ML

Marketing resumed · Not specified
Active ingredient: DIAZEPAM

Notice details →
Czechia

DOSPELIN 10MG TBL FLM 60

Unterbrechung des Inverkehrbringens · Commercial/marketing reasons
Active ingredient: DONEPEZIL

Notice details →
Czechia

DOSPELIN 5MG TBL FLM 60

Unterbrechung des Inverkehrbringens · Commercial/marketing reasons
Active ingredient: DONEPEZIL

Notice details →
Czechia

ETOPOSIDE ACCORD 20MG/ML INF CNC SOL 1X12,5ML

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: ETOPOSID

Notice details →
Czechia

GLUCOSE FRESENIUS KABI 10% 100MG/ML INF SOL 10X1000ML II

Marketing resumed · Not specified
Active ingredient: CUKRY

Notice details →
Czechia

METAMIZOL STADA 500MG/ML POR GTT SOL 1X100ML

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: SODNÁ SŮL METAMIZOLU

Notice details →
Czechia

ORFIRIL 100MG/ML INJ SOL 5X3ML

Marketing resumed · Not specified
Active ingredient: KYSELINA VALPROOVÁ

Notice details →
Czechia

PREGABALIN TEVA 150MG CPS DUR 90

Unterbrechung des Inverkehrbringens · Commercial/marketing reasons
Active ingredient: PREGABALIN

Notice details →
Czechia

SITAGLIPTIN/METFORMIN STADA 50MG/1000MG TBL FLM 196

Marketing ended · Change to another SÚKL code
Active ingredient: METFORMIN A SITAGLIPTIN

Notice details →
Czechia

SITAGLIPTIN/METFORMIN STADA 50MG/850MG TBL FLM 196

Marketing ended · Change to another SÚKL code
Active ingredient: METFORMIN A SITAGLIPTIN

Notice details →
Czechia

SORAFENIB ZENTIVA 200MG TBL FLM 112X1

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: SORAFENIB

Notice details →
Czechia

XARELTO 15MG TBL FLM 28 II

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: RIVAROXABAN

Notice details →
Czechia

XARELTO 15MG TBL FLM 98 II

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: RIVAROXABAN

Notice details →
Czechia

XARELTO 20MG TBL FLM 98 II

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: RIVAROXABAN

Notice details →
Czechia

AMILIA 200MG TBL NOB 150

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: AMISULPRID

Notice details →
Czechia

AMILIA 200MG TBL NOB 30

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: AMISULPRID

Notice details →
Czechia

AMILIA 50MG TBL NOB 60

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: AMISULPRID

Notice details →
Czechia

AMLODIPIN VITABALANS 5MG TBL NOB 30

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: AMLODIPIN

Notice details →
Czechia

GABANOX 100MG CPS DUR 50

Marketing resumed · Not specified
Active ingredient: GABAPENTIN

Notice details →
Czechia

LETROX 125MCG TBL NOB 100

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: SODNÁ SŮL LEVOTHYROXINU

Notice details →
Czechia

LIOTON 1000IU/G GEL 50G

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: HEPARIN

Notice details →
Czechia

METHOTREXAT EBEWE 5MG TBL NOB 50

Marketing resumed · Not specified
Active ingredient: METHOTREXÁT

Notice details →
Czechia

MIDAZOLAM KALCEKS 5MG/ML INJ/INF SOL 10X1ML

Unterbrechung des Inverkehrbringens · Produktionsgründe
Active ingredient: MIDAZOLAM

Notice details →
Czechia

MOXONIDIN VIATRIS 0,2MG TBL FLM 98

Marketing ended · Commercial/marketing reasons
Active ingredient: MOXONIDIN

Notice details →
Czechia

MOXONIDIN VIATRIS 0,3MG TBL FLM 98

Marketing ended · Commercial/marketing reasons
Active ingredient: MOXONIDIN

Notice details →